Cell Metab 2008
The analysis included eight randomized controlled trials with 2,372 participants (all with BMI 27 kg/m) and found that weight regain was proportional to the amount initially lost.48 On average, participants who had taken liraglutide regained 2.2 kg, while those who had taken semaglutide or tirzepatide regained 9.69 kg after stopping the medication.48 Similarly, a 2025 review in Biomolecules showed that patients treated with GLP-1 or dual GLP-1/GIP agonists experience substantial weight loss (ranging from about 6% to over 20%) but also significant weight regain upon drug discontinuation
alternative contraceptive methods may be safer
To the best of our knowledge, there is only one available source (outside of sports blogs and forums) that provides information on aromatase inhibition by mesterolone (Llewellyn, 2017)
While Zepbound's mechanism of action helps counteract some of these changes by enhancing satiety signals, the body's homeostatic systems continue to exert pressure toward weight stability
Psychiatry Clin Neurosci (2010) 64(1):1927.10.1111/j.1440-1819.2009.02032.x 95 FriedrichNSchneiderHJSpielhagenCMarkusMRHaringRGrabeHJet alThe association of serum prolactin concentration with inflammatory biomarkers cross-sectional findings from the population-based Study of Health in Pomerania
_(1)44368228eb044342af44e53832b68ca4.png)
